Local expression of interleukin-27 ameliorates collagen-induced arthritis

Arthritis and Rheumatism

Volumn 63, Issue 8, 2011, Pages 2289-2298

  Pickens, Sarah R ^a   Chamberlain, Nathan D ^a   Volin, Michael V ^b   Mandelin II, Arthur M ^a   Agrawal, Hemant ^a   Matsui, Masanori ^c   Yoshimoto, Takayuki ^d   Shahrara, Shiva ^a,e  

^a NORTHWESTERN UNIVERSITY   (United States)

^b MIDWESTERN UNIVERSITY   (United States)

^c SAITAMA MEDICAL UNIVERSITY   (Japan)

^d TOKYO MEDICAL UNIVERSITY   (Japan)

^e UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; HEMOGLOBIN; INTERLEUKIN 17; INTERLEUKIN 27;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANKLE; ARTICLE; BONE EROSION; CELL MIGRATION; COLLAGEN INDUCED ARTHRITIS; CONTROLLED STUDY; DISEASE COURSE; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC TRANSFECTION; HEMOGLOBIN BLOOD LEVEL; HISTOPATHOLOGY; HYPERTROPHY; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LYMPHOCYTE DIFFERENTIATION; MONOCYTE; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; RHEUMATOID ARTHRITIS; TH17 CELL; VASCULARIZATION;

ADENOVIRIDAE; ANIMALS; ANKLE JOINT; ARTHRITIS, EXPERIMENTAL; DISEASE PROGRESSION; INTERLEUKIN-17; MICE; MICE, INBRED DBA; TRANSFECTION;

EID: 79961115376     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.30324     Document Type: Article

References (43)

1. Stamp LK, James MJ, Cleland LG,. Interleukin-17: the missing link between T-cell accumulation and effector cell actions in rheumatoid arthritis? Immunol Cell Biol 2004; 82: 1-9. (Pubitemid 38388713)
2. Lubberts E, Koenders MI, van den Berg WB,. The role of T-cell interleukin-17 in conducting destructive arthritis: lessons from animal models. Arthritis Res Ther 2005; 7: 29-37. (Pubitemid 40214525)
3. Shahrara S, Huang Q, Mandelin AM II, Pope RM,. TH-17 cells in rheumatoid arthritis. Arthritis Res Ther 2008; 10: R93.
4. Pickens SR, Volin MV, Mandelin AM II, Kolls JK, Pope RM, Shahrara S,. IL-17 contributes to angiogenesis in rheumatoid arthritis. J Immunol 2010; 184: 3233-41.
5. Shahrara S, Pickens SR, Dorfleutner A, Pope RM,. IL-17 induces monocyte migration in rheumatoid arthritis. J Immunol 2009; 182: 3884-91.
6. Shahrara S, Pickens SR, Mandelin AM II, Karpus WJ, Huang Q, Kolls JK, et al. IL-17-mediated monocyte migration occurs partially through CC chemokine ligand 2/monocyte chemoattractant protein-1 induction. J Immunol 2010; 184: 4479-87.
7. Nakae S, Nambu A, Sudo K, Iwakura Y,. Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J Immunol 2003; 171: 6173-7. (Pubitemid 37467240)
8. Lubberts E, Koenders MI, Oppers-Walgreen B, van den Bersselaar L, Coenen-de Roo CJ, Joosten LA, et al. Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion. Arthritis Rheum 2004; 50: 650-9. (Pubitemid 38198849)
9. Koenders MI, Lubberts E, van de Loo FA, Oppers-Walgreen B, van den Bersselaar L, Helsen MM, et al. Interleukin-17 acts independently of TNF-α under arthritic conditions. J Immunol 2006; 176: 6262-9.
10. + T cells. Immunity 2002; 16: 779-90. (Pubitemid 34786477)
11. Li J, Gran B, Zhang GX, Rostami A, Kamoun M,. IL-27 subunits and its receptor (WSX-1) mRNAs are markedly up-regulated in inflammatory cells in the CNS during experimental autoimmune encephalomyelitis. J Neurol Sci 2005; 232: 3-9. (Pubitemid 40585836)
12. Yoshida H, Nakaya M, Miyazaki Y,. Interleukin 27: a double-edged sword for offense and defense. J Leukoc Biol 2009; 86: 1295-303.
13. Niedbala W, Cai B, Wei X, Patakas A, Leung BP, McInnes IB, et al. Interleukin 27 attenuates collagen-induced arthritis. Ann Rheum Dis 2008; 67: 1474-9.
14. Yoshida H, Hamano S, Senaldi G, Covey T, Faggioni R, Mu S, et al. WSX-1 is required for the initiation of Th1 responses and resistance to L. major infection. Immunity 2001; 15: 569-78. (Pubitemid 33016442)
15. Chen Q, Ghilardi N, Wang H, Baker T, Xie MH, Gurney A, et al. Development of Th1-type immune responses requires the type I cytokine receptor TCCR. Nature 2000; 407: 916-20.
16. Cao Y, Doodes PD, Glant TT, Finnegan A,. IL-27 induces a Th1 immune response and susceptibility to experimental arthritis. J Immunol 2008; 180: 922-30.
17. Batten M, Li J, Yi S, Kljavin NM, Danilenko DM, Lucas S, et al. Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells. Nat Immunol 2006; 7: 929-36. (Pubitemid 44263906)
18. Stumhofer JS, Laurence A, Wilson EH, Huang E, Tato CM, Johnson LM, et al. Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system. Nat Immunol 2006; 7: 937-45. (Pubitemid 44263907)
19. Stumhofer JS, Silver JS, Laurence A, Porrett PM, Harris TH, Turka LA, et al. Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10. Nat Immunol 2007; 8: 1363-71. (Pubitemid 350131173)
20. Matsui M, Moriya O, Belladonna ML, Kamiya S, Lemonnier FA, Yoshimoto T, et al. Adjuvant activities of novel cytokines, interleukin-23 (IL-23) and IL-27, for induction of hepatitis C virus-specific cytotoxic T lymphocytes in HLA-A*0201 transgenic mice. J Virol 2004; 78: 9093-104. (Pubitemid 39096520)
21. Shahrara S, Amin MA, Woods JM, Haines GK, Koch AE,. Chemokine receptor expression and in vivo signaling pathways in the joints of rats with adjuvant-induced arthritis. Arthritis Rheum 2003; 48: 3568-83. (Pubitemid 37531925)
22. Shahrara S, Proudfoot AE, Woods JM, Ruth JH, Amin MA, Park CC, et al. Amelioration of rat adjuvant-induced arthritis by Met-RANTES. Arthritis Rheum 2005; 52: 1907-19. (Pubitemid 40852900)
23. Shahrara S, Proudfoot AE, Park CC, Volin MV, Haines GK, Woods JM, et al. Inhibition of monocyte chemoattractant protein-1 ameliorates rat adjuvant-induced arthritis. J Immunol 2008; 180: 3447-56.
24. Kennedy A, Ng CT, Biniecka M, Saber T, Taylor C, O'Sullivan J, et al. Angiogenesis and blood vessel stability in inflammatory arthritis. Arthritis Rheum 2010; 62: 711-21.
25. Ruth JH, Volin MV, Haines GK III, Woodruff DC, Katschke KJ Jr, Woods JM, et al. Fractalkine, a novel chemokine in rheumatoid arthritis and in rat adjuvant-induced arthritis. Arthritis Rheum 2001; 44: 1568-81. (Pubitemid 32642219)
26. Koch AE, Nickoloff BJ, Holgersson J, Seed B, Haines GK, Burrows JC, et al. 4A11, a monoclonal antibody recognizing a novel antigen expressed on aberrant vascular endothelium: upregulation in an in vivo model of contact dermatitis. Am J Pathol 1994; 144: 244-59. (Pubitemid 24165946)
27. Haas CS, Amin MA, Ruth JH, Allen BL, Ahmed S, Pakozdi A, et al. In vivo inhibition of angiogenesis by interleukin-13 gene therapy in a rat model of rheumatoid arthritis. Arthritis Rheum 2007; 56: 2535-48. (Pubitemid 47237272)
28. Park CC, Morel JC, Amin MA, Connors MA, Harlow LA, Koch AE,. Evidence of IL-18 as a novel angiogenic mediator. J Immunol 2001; 167: 1644-53. (Pubitemid 32703167)
29. Bush KA, Farmer KM, Walker JS, Kirkham BW,. Reduction of joint inflammation and bone erosion in rat adjuvant arthritis by treatment with interleukin-17 receptor IgG1 Fc fusion protein. Arthritis Rheum 2002; 46: 802-5. (Pubitemid 34214263)
30. Lubberts E, van den Bersselaar L, Oppers-Walgreen B, Schwarzenberger P, Coenen-de Roo CJ, Kolls JK, et al. IL-17 promotes bone erosion in murine collagen-induced arthritis through loss of the receptor activator of NF-ÎB ligand/osteoprotegerin balance. J Immunol 2003; 170: 2655-62. (Pubitemid 36245658)
31. Kotake S, Sato K, Kim KJ, Takahashi N, Udagawa N, Nakamura I, et al. Interleukin-6 and soluble interleukin-6 receptors in the synovial fluids from rheumatoid arthritis patients are responsible for osteoclast-like cell formation. J Bone Miner Res 1996; 11: 88-95. (Pubitemid 26026748)
32. Romas E, Gillespie MT, Martin TJ,. Involvement of receptor activator of NFÎB ligand and tumor necrosis factor-α in bone destruction in rheumatoid arthritis. Bone 2002; 30: 340-6. (Pubitemid 34154863)
33. H-17 cells requires transforming growth factor-β and induction of the nuclear receptor RORÎt. Nat Immunol 2008; 9: 641-9. (Pubitemid 351714729)
34. H-17 responses. Nat Immunol 2008; 9: 650-7. (Pubitemid 351712635)
35. Annunziato F, Cosmi L, Liotta F, Maggi E, Romagnani S,. Type 17 T helper cells-origins, features and possible roles in rheumatic disease. Nat Rev Rheumatol 2009; 5: 325-31.
36. Koenders MI, Devesa I, Marijnissen RJ, Abdollahi-Roodsaz S, Boots AM, Walgreen B, et al. Interleukin-1 drives pathogenic Th17 cells during spontaneous arthritis in interleukin-1 receptor antagonist-deficient mice. Arthritis Rheum 2008; 58: 3461-70.
37. Fujimoto M, Serada S, Mihara M, Uchiyama Y, Yoshida H, Koike N, et al. Interleukin-6 blockade suppresses autoimmune arthritis in mice by the inhibition of inflammatory Th17 responses. Arthritis Rheum 2008; 58: 3710-9.
38. Lee JH, Cho ML, Kim JI, Moon YM, Oh HJ, Kim GT, et al. Interleukin 17 (IL-17) increases the expression of Toll-like receptor-2, 4, and 9 by increasing IL-1β and IL-6 production in autoimmune arthritis. J Rheumatol 2009; 36: 684-92.
39. Lemos HP, Grespan R, Vieira SM, Cunha TM, Verri WA Jr, Fernandes KS, et al. Prostaglandin mediates IL-23/IL-17-induced neutrophil migration in inflammation by inhibiting IL-12 and IFNÎ production. Proc Natl Acad Sci U S A 2009; 106: 5954-9.
40. Luzza F, Parrello T, Monteleone G, Sebkova L, Romano M, Zarrilli R, et al. Up-regulation of IL-17 is associated with bioactive IL-8 expression in Helicobacter pylori-infected human gastric mucosa. J Immunol 2000; 165: 5332-7.
41. Szekanecz Z, Koch AE,. Angiogenesis and its targeting in rheumatoid arthritis. Vascul Pharmacol 2009; 51: 1-7.
42. Mould AW, Tonks ID, Cahill MM, Pettit AR, Thomas R, Hayward NK, et al. Vegfb gene knockout mice display reduced pathology and synovial angiogenesis in both antigen-induced and collagen-induced models of arthritis. Arthritis Rheum 2003; 48: 2660-9. (Pubitemid 37129444)
43. Numasaki M, Watanabe M, Suzuki T, Takahashi H, Nakamura A, McAllister F, et al. IL-17 enhances the net angiogenic activity and in vivo growth of human non-small cell lung cancer in SCID mice through promoting CXCR-2-dependent angiogenesis. J Immunol 2005; 175: 6177-89. (Pubitemid 41508106)